3
Announcements
Trials
Browse
Landscape
Phase
Phase 4
1
Phase 2
1
Status
Completed
14
Terminated
5
Recruiting
4
Withdrawn
2
Unknown
2
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
CNS
2
Other hematologic neoplasm
1
Lymphoid
1
Conditions
Brain Neoplasms
264
Glioblastoma
193
Glioma
159
Neuroblastoma
56
Central Nervous System Neoplasms
55
Astrocytoma
45
Carcinoma, Non-Small-Cell Lung
39
Neoplasms
32
Breast Neoplasms
27
Oligodendroglioma
26
Meningioma
23
Recurrence
21
Neuroma, Acoustic
21
Neoplasm Metastasis
20
Meningeal Carcinomatosis
20
Gliosarcoma
20
Neurofibromatosis 1
18
Medulloblastoma
18
Lung Neoplasms
15
Paraganglioma
14
Lymphoma
14
Pheochromocytoma
13
Spinal Cord Neoplasms
12
Sarcoma
12
Precursor Cell Lymphoblastic Leukemia-Lymphoma
10
Burkitt Lymphoma
9
Pancreatic Neoplasms
8
Ovarian Neoplasms
7
Melanoma
7
Esophageal Neoplasms
7
Interventions
Sodium Chloride
1
Saline Solution
1
Dexmedetomidine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Unknown
×
Central Nervous System Diseases
×
CNS
×
Clear all
NCT01593488
2023-03-24
CILI
National Cancer Institute, Naples
Phase 2
Unknown
31 enrolled
NCT04399343
2021-01-28
DEPOD
Capital Medical University
Phase 4
Unknown
700 enrolled